Lifestyle improvement or anti-dementia drugs in Alzheimer’s disease

Fumitoshi NiwaDepartment of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan; ;Department of Neurology, North Medical Center, Kyoto Prefectural University of Medicine, Yosano-cho, Japan; Correspondence[email protected]

Toshiki MizunoDepartment of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan; Correspondence[email protected]

Masanori NakagawaMedical Innovation and Translational Medical Science, Kyoto Prefectural University of Medicine, Kyoto, JapanCorrespondence[email protected]

References

Deschaintre Y, Richard F, Leys D, et al. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology. 2009;73:674–680.
PubMed Web of Science ®Google Scholar
Kapaki E, Paraskevas GP. The cognitive effects of cholinesterase inhibitor treatment in every-day practice. Curr Med Res Opin. 2005;21:871–875.
PubMed Web of Science ®Google Scholar
Wattmo C, Minthon L, Wallin ÅK. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy. Alzheimers Res Ther. 2016;8:7.
PubMed Web of Science ®Google Scholar
Perera G, Khondoker M, Broadbent M, et al. Factors associated with response to acetylcholinesterase inhibition in dementia: a cohort study from a secondary mental health care case register in London. PLoS One. 2014;9:e109484.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Lifestyle improvement or anti-dementia drugs in Alzheimer’s disease

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Lifestyle improvement or anti-dementia drugs in Alzheimer’s disease

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date